Suchergebnisse - "Azithromycin therapeutic use"

Evolutionary dynamics in the genome of ocular Chlamydia trachomatis strains from Northern Tanzania following mass drug administration

Autoren: Ehsan Ghasemian Athumani Ramadhani Anna Harte et al.

Quelle: Microb Genom
Microbial genomics, vol. 11, no. 7

Schlagwörter: Chlamydia trachomatis/genetics, Chlamydia trachomatis/drug effects, Chlamydia trachomatis/classification, Chlamydia trachomatis/isolation & purification, Tanzania/epidemiology, Humans, Trachoma/microbiology, Trachoma/drug therapy, Trachoma/epidemiology, Phylogeny, Mass Drug Administration, Genome, Bacterial, Genotype, Anti-Bacterial Agents/therapeutic use, Anti-Bacterial Agents/administration & dosage, Longitudinal Studies, Evolution, Molecular, Child, Preschool, Polymorphism, Single Nucleotide, Whole Genome Sequencing, Male, Female, Child, Azithromycin/therapeutic use, Azithromycin/administration & dosage, Chlamydia trachomatis, Tanzania, evolution, mass drug administration (MDA), trachoma, whole-genome sequencing (WGS), Evolution and Responses to Interventions

Dateibeschreibung: application/pdf

Zugangs-URL: http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F7A4F6915CA78
https://serval.unil.ch/notice/serval:BIB_F7A4F6915CA7
https://serval.unil.ch/resource/serval:BIB_F7A4F6915CA7.P001/REF.pdf

High cure rates of Mycoplasma genitalium following empiric treatment with azithromycin alongside frequent detection of macrolide resistance in Austria

Autoren: David Chromy Lisa Starossek Katharina Grabmeier-Pfistershammer et al.

Quelle: Infection

Schlagwörter: Male, Adult, 0301 basic medicine, Mycoplasma Infections/epidemiology [MeSH], Mycoplasma Infections/drug therapy [MeSH], Male [MeSH], Drug Resistance, Bacterial [MeSH], Homosexuality, Male/statistics, Macrolides/therapeutic use [MeSH], Prevalence [MeSH], Female [MeSH], Mycoplasma Infections/microbiology [MeSH], Anti-Bacterial Agents/therapeutic use [MeSH], Men who have sex with men, Adult [MeSH], Mycoplasma genitalium/genetics [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Macrolide resistance, Mycoplasma genitalium/drug effects [MeSH], Azithromycin/therapeutic use [MeSH], Macrolides/pharmacology [MeSH], Azithromycin, Azithromycin/pharmacology [MeSH], Research, Anti-Bacterial Agents/pharmacology [MeSH], Young Adult [MeSH], Austria/epidemiology [MeSH], Medizin, Mycoplasma genitalium, Middle Aged, Anti-Bacterial Agents, Young Adult, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Austria, Drug Resistance, Bacterial, Prevalence, Humans, Mycoplasma Infections, Female, Macrolides, Homosexuality, Male

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38649669
https://repository.publisso.de/resource/frl:6505932
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85190838532
https://doi.org/10.1007/s15010-024-02261-6
https://www.ncbi.nlm.nih.gov/pubmed/38649669

A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study

Autoren: Meyer Sauteur, Patrick M Seiler, Michelle Tilen, Romy et al.

Weitere Verfasser: Meyer Sauteur, Patrick M Seiler, Michelle Tilen, Romy et al.

Quelle: Trials
Trials, Vol 25, Iss 1, Pp 1-20 (2024)
Trials, vol. 25, no. 1, pp. 655

Schlagwörter: Male, Colonization, Medicine (General), Time Factors, Adolescent, Respiratory tract infection, Resistance, 610 Medicine & health, Equivalence Trials as Topic, Azithromycin, Study Protocol, R5-920, Double-Blind Method, Pneumonia, Mycoplasma, Diagnosis, 2736 Pharmacology (medical), Humans, Multicenter Studies as Topic, Stewardship, Child, Carriage, Atypical pneumonia, Age Factors, 2701 Medicine (miscellaneous), 10060 Epidemiology, Biostatistics and Prevention Institute (EBPI), Pneumonia, Mycoplasma/drug therapy, Pneumonia, Mycoplasma/microbiology, Pneumonia, Mycoplasma/diagnosis, Community-Acquired Infections/drug therapy, Community-Acquired Infections/microbiology, Community-Acquired Infections/diagnosis, Anti-Bacterial Agents/therapeutic use, Anti-Bacterial Agents/adverse effects, Child, Preschool, Mycoplasma pneumoniae/drug effects, Treatment Outcome, Azithromycin/therapeutic use, Azithromycin/adverse effects, Switzerland, Female, Macrolides/therapeutic use, Macrolides/adverse effects, Anti-inflammatory, Antimicrobial, Anti-Bacterial Agents, Mycoplasma pneumoniae, Community-Acquired Infections, 10036 Medical Clinic, Macrolides

Dateibeschreibung: application/pdf; randomizedcontrolled_meyersauteur_trials_s13063_024_08438_6.pdf - application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39363201
https://doaj.org/article/eb0e92befef446dbb3aa3b6815762a10
https://serval.unil.ch/notice/serval:BIB_AEC07A6E7844
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_AEC07A6E78445
https://serval.unil.ch/resource/serval:BIB_AEC07A6E7844.P001/REF.pdf

Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial

Autoren: Tamarelle, Jeanne Penaud, Benjamin Tyssandier, Benjamin et al.

Weitere Verfasser: Tamarelle, Jeanne Penaud, Benjamin Tyssandier, Benjamin et al.

Quelle: Clinical microbiology and infection, vol. 29, no. 8, pp. 1056-1062

Schlagwörter: [SDE] Environmental Sciences, Microbiota, Female, Humans, Azithromycin/pharmacology, Azithromycin/therapeutic use, Doxycycline/pharmacology, Doxycycline/therapeutic use, Chlamydia trachomatis/genetics, RNA, Ribosomal, 16S/genetics, Cross-Sectional Studies, Chlamydia Infections/drug therapy, Chlamydia Infections/microbiology, Anti-Bacterial Agents/pharmacology, Anti-Bacterial Agents/therapeutic use, Vagina/microbiology, Urinary Tract Infections/drug therapy, 16S rRNA gene sequencing, Antibiotics, Chlamydia trachomatis treatment, Community state types, Vaginal microbiome, Chlamydia trachomatis, Azithromycin, Chlamydia Infections, 3. Good health, Anti-Bacterial Agents, Doxycycline, RNA, Ribosomal, 16S, [SDE]Environmental Sciences, Vagina, Urinary Tract Infections

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37100225
https://serval.unil.ch/notice/serval:BIB_8E4172B83661
https://serval.unil.ch/resource/serval:BIB_8E4172B83661.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8E4172B836613

Rare manifestations of cutaneous diphtheria: a case report

Autoren: Salma Ali Suwaid Aliyu Mustapha Monika Ried et al.

Quelle: J Med Case Rep
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-4 (2024)

Schlagwörter: Adolescent, Corynebacterium diphtheriae, Nigeria, Case Report, Diphtheria, Azithromycin, Cutaneous diphtheria, Hydrogen peroxide, Sitz baths, Diphtheria Antitoxin, Anti-Bacterial Agents, Medicine, Humans, Female, Corynebacterium diphtheriae/isolation, Adolescent [MeSH], Female [MeSH], Anti-Bacterial Agents/therapeutic use [MeSH], Diphtheria/drug therapy [MeSH], Humans [MeSH], Psychosocial context, Diphtheria/diagnosis [MeSH], Azithromycin/therapeutic use [MeSH], Diphtheria Antitoxin/therapeutic use [MeSH], Pseudomembrane, Nigeria [MeSH]

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39243108
https://doaj.org/article/27e53cb113ea49e096cf9579c1b92edf
https://repository.publisso.de/resource/frl:6522987

A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides

Autoren: Mihailo Banjanac Radan Spaventi Domingo Gargallo-Viola et al.

Quelle: Br J Pharmacol
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Universidad Carlos III de Madrid (UC3M)

Schlagwörter: Azalide, In vivo efficacy, Medicina, Plasmodium falciparum, malaria, Antimalarial, Azithromycin, antimalarial, azalide, in vivo efficacy, macrolide, mode of action, pharmacokinetics, Antimalarials, Mice, 03 medical and health sciences, Dogs, 0302 clinical medicine, Animals, Pharmacokinetics, Chloroquine / therapeutic use, Biología y Biomedicina, Antimalarials* / pharmacology, Chloroquine, Chloroquine / pharmacology, Research Papers, Malaria* / drug therapy, Malaria, Rats, 3. Good health, Mode of action, Azithromycin / therapeutic use, Macrolide, Antimalarials* / therapeutic use, Azithromycin / pharmacology

Dateibeschreibung: application/pdf

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.15292
https://pubmed.ncbi.nlm.nih.gov/33085774
https://www.bib.irb.hr/1192491
https://doi.org/10.1111/bph.15292
https://hdl.handle.net/10016/46675
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.15292
https://pubmed.ncbi.nlm.nih.gov/33085774/
https://www.ncbi.nlm.nih.gov/pubmed/33085774

Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship

Autoren: Rothe, Kathrin Feihl, Susanne Schneider, Jochen et al.

Quelle: Eur J Clin Microbiol Infect Dis
European Journal of Clinical Microbiology & Infectious Diseases

Schlagwörter: Microbiology (medical), Adult, 0301 basic medicine, Antifungal Agents, Adolescent, Azithromycin, Cohort Studies, Antimicrobial Stewardship, 03 medical and health sciences, Germany, Aspergillosis, Humans, Escherichia coli Infections, Aged, Aged, 80 and over, 0303 health sciences, Coinfection, Enterobacteriaceae Infections, COVID-19, Meropenem/therapeutic use [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Enterobacteriaceae Infections/drug therapy [MeSH], Escherichia coli Infections/epidemiology [MeSH], Antimicrobial Stewardship [MeSH], Escherichia coli Infections/drug therapy [MeSH], Klebsiella Infections/drug therapy [MeSH], Germany/epidemiology [MeSH], Cohort Studies [MeSH], Antibiotic stewardship, Original Article, Male [MeSH], Aspergillosis/drug therapy [MeSH], Streptococcal Infections/drug therapy [MeSH], Sulbactam/therapeutic use [MeSH], COVID-19/epidemiology [MeSH], SARS-CoV-2 [MeSH], Streptococcal Infections/epidemiology [MeSH], Adolescent [MeSH], Female [MeSH], Coinfection/epidemiology [MeSH], Anti-Bacterial Agents/therapeutic use [MeSH], Adult [MeSH], Linezolid/therapeutic use [MeSH], Diagnostic stewardship, Humans [MeSH], Bacterial co-infections, Aspergillosis/epidemiology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Staphylococcal Infections/drug therapy [MeSH], Azithromycin/therapeutic use [MeSH], Vancomycin/therapeutic use [MeSH], Bacterial Infections/drug therapy [MeSH], Piperacillin, Tazobactam Drug Combination/therapeutic use [MeSH], Staphylococcal Infections/epidemiology [MeSH], Young Adult [MeSH], Ampicillin/therapeutic use [MeSH], Antifungal Agents/therapeutic use [MeSH], Enterobacteriaceae Infections/epidemiology [MeSH], Bacterial Infections/epidemiology [MeSH], Klebsiella Infections/epidemiology [MeSH], Practice Patterns, Physicians'/statistics, General Medicine, Bacterial Infections, ddc, Anti-Bacterial Agents, Klebsiella Infections, 3. Good health, Infectious Diseases, Ampicillin, Female

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s10096-020-04063-8.pdf
https://pubmed.ncbi.nlm.nih.gov/33140176
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605734
https://www.scilit.net/article/6dbb47a59f2c6f8df602ebbfff0b45e9
https://paperity.org/p/257966035/rates-of-bacterial-co-infections-and-antimicrobial-use-in-covid-19-patients-a
https://pubmed.ncbi.nlm.nih.gov/33140176/
http://www.ncbi.nlm.nih.gov/pubmed/33140176
http://pubmed.ncbi.nlm.nih.gov/33140176/
https://repository.publisso.de/resource/frl:6468136
https://mediatum.ub.tum.de/doc/1585076/document.pdf

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Autoren: Jeanna Knoble Genevieve M. Boland Grace Shaw et al.

Weitere Verfasser: Jeanna Knoble Genevieve M. Boland Grace Shaw et al.

Quelle: Lancet
Lancet, vol. 395, no. 10241, pp. 1907-1918
The Lancet, vol 395, iss 10241
The Lancet

Schlagwörter: Male, Biomedical and clinical sciences, Databases, Factual, Coronaviruses, Clinical impact of COVID-19, Comorbidity, Azithromycin, Medical and Health Sciences, 0302 clinical medicine, COVID-19 and Cancer Consortium, Risk Factors, Cause of Death, Neoplasms, Viral, Lung, Cancer, 2. Zero hunger, General Medicine, Articles, Aged, Antiviral Agents/therapeutic use, Azithromycin/therapeutic use, Betacoronavirus, Coronavirus Infections/drug therapy, Coronavirus Infections/epidemiology, Coronavirus Infections/mortality, Female, Humans, Hydroxychloroquine/therapeutic use, Middle Aged, Neoplasms/epidemiology, Neoplasms/mortality, Neoplasms/therapy, Pandemics, Pneumonia, Viral/drug therapy, Pneumonia, Viral/epidemiology, Pneumonia, Viral/mortality, Prognosis, 3. Good health, Infectious Diseases, Oncology, Coronavirus Infections, Hydroxychloroquine, Clinical Sciences, Oncology and Carcinogenesis, Pneumonia, Viral, Antiviral Agents, Databases, 03 medical and health sciences, Síndrome respiratorio agudo grave, General & Internal Medicine, Health Sciences, Factual, Biomedical and Clinical Sciences, Patients with cancer, SARS-CoV-2, Prevention, Health sciences, COVID-19, Pneumonia, COVID-19 Drug Treatment, Coronavirus, Emerging Infectious Diseases, Good Health and Well Being

Dateibeschreibung: application/pdf; 12 páginas; image/jepg; image/png

Zugangs-URL: http://www.thelancet.com/article/S0140673620311879/pdf
https://pubmed.ncbi.nlm.nih.gov/32473681
https://serval.unil.ch/resource/serval:BIB_B3D837E39CC4.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_B3D837E39CC4
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_B3D837E39CC42
https://escholarship.org/uc/item/9d33v85q
https://escholarship.org/content/qt9d33v85q/qt9d33v85q.pdf

Novel Chlamydia species isolated from snakes are temperature-sensitive and exhibit decreased susceptibility to azithromycin.

Autoren: Staub, E. Marti, H. Biondi, R. et al.

Schlagwörter: Animals, Anti-Bacterial Agents/therapeutic use, Azithromycin/therapeutic use, Chlamydia/classification, Chlamydia/drug effects, Chlamydia/genetics, Chlamydia Infections/drug therapy, Chlamydia Infections/microbiology, Chlamydia Infections/veterinary, Drug Resistance, Bacterial, Genome, Metagenomics, Phylogeny, Snakes/microbiology, Temperature, Whole Genome Sequencing

Dateibeschreibung: application/pdf

Relation: Scientific Reports; https://iris.unil.ch/handle/iris/71582; serval:BIB_33295F4DC436; 000429095600069

Verfügbarkeit: https://iris.unil.ch/handle/iris/71582
https://doi.org/10.1038/s41598-018-23897-z

Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.

Autoren: Balaskas, K. Vaudaux, J. Boillat-Blanco, N. et al.

Schlagwörter: Adult, Antiprotozoal Agents/therapeutic use, Azithromycin/therapeutic use, Chorioretinitis/drug therapy, Chorioretinitis/physiopathology, Female, Humans, Male, Middle Aged, Pilot Projects, Prospective Studies, Pyrimethamine/therapeutic use, Sulfadiazine/therapeutic use, Toxoplasmosis, Ocular/drug therapy, Ocular/physiopathology

Dateibeschreibung: application/pdf

Relation: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research; https://iris.unil.ch/handle/iris/220518; serval:BIB_8289BEB90EE5; 000304535900013

Verfügbarkeit: https://iris.unil.ch/handle/iris/220518
https://doi.org/10.12659/MSM.882735

Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation

Autoren: Vallet, Nicolas Le Grand, Sophie Bondeelle, Louise et al.

Quelle: ISSN: 0006-4971 ; Blood, vol. 140, no. 23 (2022) p. 2500-2513.

Schlagwörter: info:eu-repo/classification/ddc/616, Humans, Azithromycin / pharmacology, Azithromycin / therapeutic use, Hematopoietic Stem Cell Transplantation, Metabolic Networks and Pathways, Neoplasms, Stem Cell Transplantation

Relation: info:eu-repo/semantics/altIdentifier/pmid/35984904; info:eu-repo/semantics/dataset/url/http://flowrepository.org/id/FR-FCM-Z5ZB; info:eu-repo/semantics/dataset/url/http://flowrepository.org/id/FR-FCM-Z5L7; info:eu-repo/semantics/dataset/url/https://www.ebi.ac.uk/metabolights/editor/MTBLS406; info:eu-repo/semantics/dataset/url/https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE197658; info:eu-repo/semantics/dataset/url/https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208399; info:eu-repo/semantics/dataset/url/https://gitlab.com/nivall/azimut-blood; info:eu-repo/semantics/dataset/url/https://gitlab.com/nivall/azimut-in-vitro; info:eu-repo/semantics/dataset/url/https://gitlab.com/nivall/azimutscrna; unige:169063

Verfügbarkeit: https://archive-ouverte.unige.ch/unige:169063

Use of repurposed and adjuvant drugs in hospital patients with covid-19:Multinational network cohort study

Autoren: Prats-Uribe, Albert Sena, Anthony G. Lai, Lana Yin Hui et al.

Quelle: Prats-Uribe, A, Sena, A G, Lai, L Y H, Ahmed, W U R, Alghoul, H, Alser, O, Alshammari, T M, Areia, C, Carter, W, Casajust, P, Dawoud, D, Golozar, A, Jonnagaddala, J, Mehta, P P, Gong, M, Morales, D R, Nyberg, F, Posada, J D, Recalde, M, Roel, E, Shah, K, Shah, N H, Schilling, L M, Subbian, V, Vizcaya, D, Zhang, L, Zhang, Y, Zhu, H, Liu, L, Cho, J, Lynch, K E, Matheny, M E, You, S C, Rijnbeek, P R, Hripcsak, G, Lane, J C E, Burn, E, Reich, C, Suchard, M A, Duarte-Salles, T, Kostka, ....

Schlagwörter: Administrative Claims, Healthcare/statistics & numerical data, Adolescent, Adrenal Cortex Hormones/therapeutic use, Adult, Aged, 80 and over, Azithromycin/therapeutic use, COVID-19/diagnosis, Ceftriaxone/therapeutic use, Chemotherapy, Adjuvant/methods, Child, Preschool, China/epidemiology, Cohort Studies, Drug Combinations, Drug Repositioning/methods, Electronic Health Records/statistics & numerical data, Enoxaparin/therapeutic use, Female, Fluoroquinolones/therapeutic use, Humans, Hydroxychloroquine/therapeutic use, Infant, Newborn, Inpatients, Lopinavir/therapeutic use, Male, Middle Aged

Dateibeschreibung: application/pdf

Verfügbarkeit: https://portal.findresearcher.sdu.dk/da/publications/c0b4c38a-de1a-4e41-a55c-558e7d8fbb4e
https://doi.org/10.1136/bmj.n1038
https://findresearcher.sdu.dk/ws/files/182690792/Prats_uribe_2021_Use_of_repurposed_and_adjuvant_drug.pdf

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

Autoren: RECOVERY Collaborative Group Dhasmana, Devesh J University of St Andrews.School of Medicine

Weitere Verfasser: RECOVERY Collaborative Group Dhasmana, Devesh J University of St Andrews.School of Medicine

Schlagwörter: Azithromycin/therapeutic use, COVID-19/drug therapy, Female, Hospital mortality, Hospitalization, Humans, Length of stay, Male, Middle aged, Survival rate, Treatment outcome, United Kingdom, RA0421 Public health. Hygiene. Preventive Medicine, RM Therapeutics. Pharmacology, 3rd-DAS, SDG 3 - Good Health and Well-being, NIS, RA0421, RM

Dateibeschreibung: application/pdf

Relation: Lancet; 275408069; 85100615475; PubMedCentral: PMC7884931; https://hdl.handle.net/10023/24234

Verfügbarkeit: https://hdl.handle.net/10023/24234
https://doi.org/10.1016/S0140-6736(21)00149-5

Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.

Autoren: Fiolet, T. Guihur, A. Rebeaud, M.E. et al.

Quelle: Clinical microbiology and infection, vol. 27, no. 1, pp. 138-140

Schlagwörter: Antiviral Agents/therapeutic use, Azithromycin/therapeutic use, COVID-19/drug therapy, COVID-19/mortality, COVID-19/prevention & control, Chloroquine/therapeutic use, Drug Therapy, Combination, Humans, Hydroxychloroquine/therapeutic use, SARS-CoV-2/drug effects, Treatment Outcome

Dateibeschreibung: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/33080383; info:eu-repo/semantics/altIdentifier/eissn/1469-0691; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_0A95964B9D1D4; https://serval.unil.ch/notice/serval:BIB_0A95964B9D1D; https://serval.unil.ch/resource/serval:BIB_0A95964B9D1D.P001/REF.pdf

Verfügbarkeit: https://serval.unil.ch/notice/serval:BIB_0A95964B9D1D
https://doi.org/10.1016/j.cmi.2020.10.002
https://serval.unil.ch/resource/serval:BIB_0A95964B9D1D.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_0A95964B9D1D4

Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response.

Autoren: Fiolet, T. Guihur, A. Rebeaud, M.E. et al.

Quelle: Clinical microbiology and infection, vol. 27, no. 6, pp. 920-921

Schlagwörter: Azithromycin/therapeutic use, COVID-19/drug therapy, Humans, Hydroxychloroquine/therapeutic use, SARS-CoV-2

Dateibeschreibung: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/33166647; info:eu-repo/semantics/altIdentifier/eissn/1469-0691; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B692879BE8C91; https://serval.unil.ch/notice/serval:BIB_B692879BE8C9; https://serval.unil.ch/resource/serval:BIB_B692879BE8C9.P001/REF.pdf

Verfügbarkeit: https://serval.unil.ch/notice/serval:BIB_B692879BE8C9
https://doi.org/10.1016/j.cmi.2020.10.031
https://serval.unil.ch/resource/serval:BIB_B692879BE8C9.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_B692879BE8C91

Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19

Autoren: Brazão,Stephani Correia Autran,Lis Jappour Lopes,Rosane de Oliveira et al.

Quelle: International Journal of Cardiovascular Sciences v.34 n.2 2021

Schlagwörter: Cardiovascular System, Chloroquine/toxicity, Hydroxychloroquine/toxicity, Betacoronavirus, COVID-19, Azithromycin/ therapeutic use

Dateibeschreibung: text/html

Verfügbarkeit: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021000200211

Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19

Autoren: Stephani Correia Brazão Lis Jappour Autran Rosane de Oliveira Lopes et al.

Quelle: International Journal of Cardiovascular Sciences v.34 n.2 2021
International Journal of Cardiovascular Sciences
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
International Journal of Cardiovascular Sciences, Volume: 34, Issue: 2, Pages: 211-222, Published: 26 FEB 2021
International Journal of Cardiovascular Sciences, Issue: ahead, Published: 26 FEB 2021

Schlagwörter: Betacoronavirus, 03 medical and health sciences, Hydroxychloroquine/toxicity, 0302 clinical medicine, COVID-19, Chloroquine/toxicity, Cardiovascular System, Azithromycin/ therapeutic use, 3. Good health

Dateibeschreibung: text/html

Zugangs-URL: https://ijcscardiol.org/wp-content/uploads/articles_xml/2359-4802-ijcs-34-02-0211/2359-4802-ijcs-34-02-0211.pdf
https://www.academicoo.com/artigo/effects-of-chloroquine-and-hydroxychloroquine-on-the-cardiovascular-system-limitations-for-use-in-the-treatment-of-covid-19
https://www.scielo.br/j/ijcs/a/h9bGrtxkS9JwqVVjh7nVmGv/
https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1154542
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021000200211
https://ijcscardiol.org/article/effects-of-chloroquine-and-hydroxychloroquine-on-the-cardiovascular-system-limitations-for-use-in-the-treatment-of-covid-19/
http://www.scielo.br/pdf/ijcs/v34n2/2359-4802-ijcs-20200162.pdf
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021000200211
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021000200211&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005003204&lng=en&tlng=en

Conjonctivite à chlamydia trachomatis. ; Chlamydia trachomatis conjunctivitis

Autoren: Terlinchamp, Mathieu Duchesne, Bernard

Quelle: Journal Français d'Ophtalmologie, 43 (1), e21-e22 (2020)

Schlagwörter: Azithromycin/therapeutic use, Chlamydia trachomatis/isolation & purification, Conjunctivitis, Inclusion/diagnosis/drug therapy/microbiology, Viral/diagnosis, Diagnosis, Differential, Humans, Male, Young Adult, Human health sciences, Ophthalmology, Sciences de la santé humaine, Ophtalmologie

Relation: urn:issn:0181-5512; urn:issn:1773-0597; https://orbi.uliege.be/handle/2268/256106; info:hdl:2268/256106; https://orbi.uliege.be/bitstream/2268/256106/1/Conjonctivite%20%c3%a0%20chlamydia%20trachomatis.pdf; info:pmid:31753423

Verfügbarkeit: https://orbi.uliege.be/handle/2268/256106
https://orbi.uliege.be/bitstream/2268/256106/1/Conjonctivite%20%c3%a0%20chlamydia%20trachomatis.pdf
https://doi.org/10.1016/j.jfo.2019.03.036

Conjonctivite à chlamydia trachomatis.
Chlamydia trachomatis conjunctivitis

Autoren: Terlinchamp, Mathieu Duchesne, Bernard

Quelle: Journal Français d'Ophtalmologie, 43 (1), e21-e22 (2020)

Schlagwörter: Azithromycin/therapeutic use, Chlamydia trachomatis/isolation & purification, Conjunctivitis, Inclusion/diagnosis/drug therapy/microbiology, Conjunctivitis, Viral/diagnosis, Diagnosis, Differential, Humans, Male, Young Adult, Human health sciences, Ophthalmology, Sciences de la santé humaine, Ophtalmologie

Relation: urn:issn:0181-5512; urn:issn:1773-0597

Zugangs-URL: https://orbi.uliege.be/handle/2268/256106

Evidence of efficacy is not enough to develop recommendations: antibiotics for treatment of traveler's diarrhea.

Autoren: Genton, B. D'Acremont, V.

Schlagwörter: Anti-Bacterial Agents/administration & dosage, Anti-Bacterial Agents/therapeutic use, Azithromycin/administration & dosage, Azithromycin/therapeutic use, Diarrhea/drug therapy, Drug Resistance, Bacterial/drug effects, Humans, Military Personnel, Ofloxacin/administration & dosage, Ofloxacin/therapeutic use, Thailand, Travel

Dateibeschreibung: application/pdf

Relation: Clinical Infectious Diseases; https://iris.unil.ch/handle/iris/89801; serval:BIB_1BB1C41C6171; 000246198800020

Verfügbarkeit: https://iris.unil.ch/handle/iris/89801
https://doi.org/10.1086/517837